Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
4(31%)
Results Posted
22%(2 trials)

Phase Distribution

Ph phase_3
2
15%
Ph phase_1
10
77%
Ph phase_2
1
8%

Phase Distribution

10

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
10(76.9%)
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
2(15.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

13

all time

Status Distribution
Active(4)
Completed(9)

Detailed Status

Completed9
Recruiting3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
4
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 110 (76.9%)
Phase 21 (7.7%)
Phase 32 (15.4%)

Trials by Status

completed969%
recruiting323%
active_not_recruiting18%

Recent Activity

4 active trials
Showing 5 of 13
recruitingphase_2

A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)

NCT07614984
recruitingphase_1

A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003)

NCT07619443
active_not_recruitingphase_3

A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)

NCT07216482
recruitingphase_1

A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)

NCT07300280
completedphase_1

A Clinical Study of the Effect of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-041)

NCT07481708
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT07614984Phase 2

A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)

Recruiting
NCT07619443Phase 1

A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003)

Recruiting
NCT07216482Phase 3

A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)

Active Not Recruiting
NCT07300280Phase 1

A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)

Recruiting
NCT07481708Phase 1

A Clinical Study of the Effect of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-041)

Completed
NCT06575959Phase 1

A Clinical Study of Enlicitide Decanoate in People With Liver Function Problems (MK-0616-030)

Completed
NCT06450366Phase 3

A Study to Evaluate the Efficacy and Safety of Enlicitide (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018/CORALreef AddOn)

Completed
NCT07044479Phase 1

A Clinical Study of How Coffee and Tea Affect Enlicitide in Healthy Volunteers (MK-0616-040)

Completed
NCT06643377Phase 1

A Clinical Study of Enlicitide in Participants With Severe Renal Impairment (MK-0616-032)

Completed
NCT06880874Phase 1

A Clinical Study to Evaluate Enlicitide (MK-0616) Formulations in Healthy Adult Participants (MK-0616-035)

Completed
NCT06719544Phase 1

A Study of Lithium and Enlicitide in Healthy Adult Participants (MK-0616-034)

Completed
NCT06609512Phase 1

A Clinical Study of Enlicitide and the Effect of Food in Healthy Adult Participants (MK-0616-033)

Completed
NCT06597760Phase 1

A Clinical Study to Assess the Effect of Enlicitide on How the Body Processes Digoxin in Healthy Adult Participants (MK-0616-031)

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13